EE311 Evaluating the Cost-Effectiveness of Ruxolitinib for the Treatment of Polycythaemia Vera Patients That Are Resistant/Intolerant to Hydroxycarbamide/Hydroxyurea in England and Wales
Abstract
Authors
R Rafia L Dunham A Liu J Brodie V Hargreaves H Skinner A Nawaz A Baeza-plaza D Andrews H Negi K Jameson